Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: Belgium Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20151
20161
20192
20212
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universitaire Ziekenhuizen KU Leuven3
Hoffmann-La Roche2
Terumo Europe N.V.2
University Hospital, Ghent2
Erasme University Hospital1
Maastricht University Medical Center1
Newcastle University1
University of Liege1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular13
Liver Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Cardiovascular Diseases1
Cholangiocarcinoma1
Diabetes Mellitus, Type 21
Dyslipidemias1
End Stage Liver Disease1
Fatty Liver1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.